משבר התרופות לגיל המעבר :"נשים נותרות ללא טיפול"

הערכה

A shortage of hormonal menopause treatments has led to ten cases of discontinued marketing or supply gaps in the last six months. Women are being forced to search multiple pharmacies to find their medication. For BRCA carriers who have undergone ovary removal, the disruption threatens their treatment continuity and could cause serious health consequences.